- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
University of Virginia opens center for ablation research
The University of Virginia has opened a state-of-the-art MR-guided focused ultrasound ablation research institute.
The University of Virginia has opened a state-of-the-art MR-guided focused ultrasound ablation research institute. It is designed to become a leading center for translational research and patient care in this new and rapidly evolving field, said provost Dr. Tim Garson on dedication day, Sept 14.
The UVA center will offer uterine fibroid therapy, the first application of the focused ultrasound technology to receive FDA approval. It will also host clinical trials on uterine fibroids and fertility; Parkinson’s disease and epilepsy; liver, brain, breast, and prostate tumors; and pain control from bone tumors. The state of Virginia and the Focused Ultrasound Surgery Foundation covered $7.1 million of the $8 million cost of establishing the institute. Other contributors included GE Healthcare and InSightec, developer of the first FDA-approved MR-guided focused ultrasound ablation system.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
